High mortality rates after both open surgical and endovascular thoracic aortic interventions in patients with end-stage renal disease

In ESRD patients, TEVAR provides short-term mortality benefits compared with open repair, but long-term mortality remains high regardless of treatment modality. Elective intervention for thoracic aortic disease in this population remains high risk and should be approached with caution.